Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec;63(23):e1801401.
doi: 10.1002/mnfr.201801401. Epub 2019 Oct 23.

Dietary Supplementation of Methyl Donor l-Methionine Alters Epigenetic Modification in Type 2 Diabetes

Umashanker Navik  1 , Vaibhav G Sheth  1 , Shaheen Wasil Kabeer  1 , Kulbhushan Tikoo  1
Affiliations

Dietary Supplementation of Methyl Donor l-Methionine Alters Epigenetic Modification in Type 2 Diabetes

Umashanker Navik et al. Mol Nutr Food Res. 2019 Dec.

Abstract

Scope: The aim of the current study is to evaluate whether l-methionine supplementation (l-Met-S) improves type 2 diabetes-induced alterations in glucose and lipid metabolism by modulating one-carbon metabolism and methylation status.

Methods and results: Diabetes is induced in male Sprague-Dawley rats using high-fat diet and low dose streptozotocin. At the end of study, various biochemical parameters, immunoblotting, qRT-PCR and ChIP-qPCR are performed. The first evidence that l-Met-S activates p-AMPK and SIRT1, very similar to "metformin," is provided. l-Met-S improves the altered key one-carbon metabolites in diabetic rats by modulating methionine adenosyl transferase 1A and cystathione β synthase expression. qRT-PCR shows that l-Met-S alleviates diabetes-induced increase in Forkhead transcription factor 1 expression and thereby regulating genes involved in glucose (G6pc, Pdk4, Pklr) and lipid metabolism (Fasn). Interestingly, l-Met-S inhibits the increased expression of DNMT1 and also prevents methylation of histone H3K36me2 under diabetic condition. ChIP assay shows that persistent increase in abundance of histone H3K36me2 on the promoter region of FOXO1 in diabetic rats and it is recovered by l-Met-S.

Conclusion: The first evidence that dietary supplementation of l-Met prevents diabetes-induced epigenetic alterations and regulating methionine levels can be therapeutically exploited for the treatment of metabolic diseases is provided.

Keywords: AMPK and FOXO1; H3K36me2; l-methionine; one-carbon metabolism; type 2 diabetes mellitus.

PubMed Disclaimer

References

    1. M. J. Franz, J. P. Bantle, C. A. Beebe, J. D. Brunzell, J. L. Chiasson, A. Garg, L. A. Holzmeister, B. Hoogwerf, E. J. Mayer-Davis, A. D. Mooradian, Diabetes Care 2003, 26, s51-s61.
    1. C. Z. Larter, S. Chitturi, D. Heydet, G. C. Farrell, J. Gastroenterol. Hepatol. 2010, 25, 672.
    1. R. Barres, M. E. Osler, J. Yan, A. Rune, T. Fritz, K. Caidahl, A. Krook, J. R. Zierath, Cell Metab. 2009, 10, 189.
    1. Z. Cheng, F. Almeida, Cell Cycle 2014, 13, 890.
    1. K. T. Williams, K. L. Schalinske, Diabetes Metab. Res. Rev. 2012, 28, 123.

Publication types

LinkOut - more resources